60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
0.9000
-0.0300 (-3.23%)
At close: Sep 11, 2026, 4:00 PM EDT
0.9006
+0.0006 (0.07%)
After-hours: Sep 11, 2026, 7:48 PM EDT
SXTP Revenue
60 Degrees Pharmaceuticals had revenue of $207.90K in the quarter ending June 30, 2026, a decrease of -32.47%. This brings the company's revenue in the last twelve months to $1.21M, up 23.41% year-over-year. In the year 2025, 60 Degrees Pharmaceuticals had annual revenue of $1.41M with 106.81% growth.
Revenue (ttm)
$1.21M
Revenue Growth
+23.41%
P/S Ratio
2.61
Revenue / Employee
$404,977
Employees
3
Market Cap
3.17M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.41M | 727.75K | 106.81% |
| Dec 31, 2024 | 681.35K | 427.77K | 168.70% |
| Dec 31, 2023 | 253.57K | -257.64K | -50.40% |
| Dec 31, 2022 | 511.21K | -5.84M | -91.95% |
| Dec 31, 2021 | 6.35M | 3.80M | 149.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PMGC Holdings | 2.58M |
| SciSparc | 856.00K |
| GeoVax Labs | 852.28K |
| Onconetix | 645.82K |
| BioRestorative Therapies | 357.87K |
| Addex Therapeutics | 136.51K |
| Silo Pharma | 54.08K |
SXTP News
- 1 day ago - 60 Degrees Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 9 days ago - 60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 4 weeks ago - 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results - GlobeNewsWire
- 4 weeks ago - 60 Degrees Pharmaceuticals Registration statement: Registration filing - Filings
- 4 weeks ago - 60 Degrees Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 4 weeks ago - 60 Degrees Pharmaceuticals Earnings release: Q2 2026 - Filings
- 6 weeks ago - 60 Degrees Pharmaceuticals to sell shares and warrants in private placement - TheFly
- 6 weeks ago - 60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire